Market Report of China’s Biopharmaceuticals Industry in 2009
Despite the impact of global financial downturn, the emerging pharmaceutical markets have made good showings. Likewise, Chinese biopharmaceuticals industry also presented growth tendency. Up till November 2009, the cumulative industrial sales value of China’s biological and biopharmaceutical product manufacturing industries rose 27.34% to RMB 78.703 billion compared to the same period of the year before with a growth rate dropping 3.95 percentage points. By analyzing China’s biopharmaceuticals industry in terms of the production, trade, market and financial information of prime products, this report makes prediction as reference about the future developing path of the national biopharmaceuticals industry.
1 PRODUCTION OF CHINA’S BIOPHARMACEUTICALS INDUSTRY
1.1 Cumulative Production
1.2 Monthly Production
1.3 Production in Major Regions
2 IMPORT & EXPORT ANALYSIS
2.1 Importation
2.2 Exportation
2.3 Trade Balance
3 MARKET COMPETITION IN CHINA’S BIOPHARMACEUTICALS INDUSTRY
4 OVERALL FINANCIAL STATUS (BY ENTERPRISES OF DIFFERENT SCALES AND ECONOMIC TYPES)
4.1 Industrial capacity for growth
4.2 Cost structure
4.3 Repayment capability
4.4 Operation capacity
5 DEVELOPMENT TREND OF CHINA’S BIOPHARMACEUTICALS INDUSTRY
1.1 Cumulative Production
1.2 Monthly Production
1.3 Production in Major Regions
2 IMPORT & EXPORT ANALYSIS
2.1 Importation
2.2 Exportation
2.3 Trade Balance
3 MARKET COMPETITION IN CHINA’S BIOPHARMACEUTICALS INDUSTRY
4 OVERALL FINANCIAL STATUS (BY ENTERPRISES OF DIFFERENT SCALES AND ECONOMIC TYPES)
4.1 Industrial capacity for growth
4.2 Cost structure
4.3 Repayment capability
4.4 Operation capacity
5 DEVELOPMENT TREND OF CHINA’S BIOPHARMACEUTICALS INDUSTRY
